On July 29th we successfully put the double-stage short-path distillation into operation at the new Canexis Pharma AG site.
The short path distillation was specially built according to Canexis' requirements. It meets the highest quality standards and is designed to process cannabis extract into cannabis distillate. When planning, we focused on the critical process parameters and a hygienic design. Canexis considered the typical GMP-V model when purchasing it. In this way, we recorded the requirements for the process (User Requirements Specification – URS), carried out a risk analysis (RA), checked the functional specification (FS) before production and carried out the design qualification (DQ). Afterwards, a proper Factory Acceptance Test (FAT) or Site Acceptance Test (SAT) was carried out and the Installation Qualification (IQ) was completed. Now we move on to the validation phase, in which the Operational Qualification (OQ) and the Performance Qualification (PQ) are on the program.
We have successfully completed the challenging task of carrying out all the steps properly. We would like to thank everyone involved in the project for their commitment and congratulate us on the successful interim result.
The system itself can produce up to 10 kg of high-quality cannabis distillate per hour. To achieve this quality, we work at the lowest possible vacuum (< 0 mbar). We also pay attention to short contacts with high temperatures and exclusion of oxygen. The product only comes into contact with FDA-certified seals or high-quality stainless steel during its journey through the facility.
